⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LGND News
Ligand Pharmaceuticals Inc.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Bronstein, Gewirtz & Grossman, LLC (XOMA) And Encourages Stockholders to Connect
accessnewswire.com
XOMA
LGND
Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement
globenewswire.com
OBIO
LGND
MDT
Ligand to Participate in May Investor Conferences
globenewswire.com
LGND
H.C. Wainwright Announces 2nd Annual Royalty Company Virtual Conference
businesswire.com
ANAB
FBRX
OMAB
ZYME
LGND
Bronstein, Gewirtz & Grossman, LLC Encourages XOMA Royalty Corporation (XOMA) Shareholders to Inquire about Securities Investigation
accessnewswire.com
XOMA
LGND
Bronstein, Gewirtz & Grossman, LLC Is Investigating XOMA Royalty Corporation (XOMA) And Encourages Shareholders to Connect
accessnewswire.com
XOMA
LGND
Bronstein, Gewirtz & Grossman, LLC Encourages XOMA Royalty Corporation (XOMA) Stockholders to Inquire about Securities Investigation
accessnewswire.com
XOMA
LGND
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against XOMA Royalty Corporation (XOMA) and Encourages Investors to Learn More About the Investigation
accessnewswire.com
XOMA
LGND
Form 8-K
sec.gov
LGNZZ
LGND
LGNYZ
LGNXZ
LGNDZ
VKTX
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against XOMA Royalty Corporation (XOMA) And Encourages Investors to Reach Out
accessnewswire.com
XOMA
LGND